Alector Inventory 2017-2025 | ALEC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Alector inventory from 2017 to 2025. Inventory can be defined as the total value of inventories in all stages of completion.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Alector inventory from 2017 to 2025. Inventory can be defined as the total value of inventories in all stages of completion.

Related Stocks
Company Name	Market Cap
AstraZeneca (AZN)	$214.8B
Amgen (AMGN)	$160.4B
Gilead Sciences (GILD)	$135.3B
Vertex Pharmaceuticals (VRTX)	$119B
Bristol Myers Squibb (BMY)	$97.8B
CSL (CSLLY)	$78.3B
GSK (GSK)	$74.7B
Regeneron Pharmaceuticals (REGN)	$59.4B
Alnylam Pharmaceuticals (ALNY)	$42.3B
Argenex SE (ARGX)	$35B
BioNTech SE (BNTX)	$26.7B
Royalty Pharma (RPRX)	$19.9B
Insmed (INSM)	$19.8B
Biogen (BIIB)	$18.9B
Illumina (ILMN)	$15.5B
Genmab (GNMSF)	$14.5B
Genmab (GMAB)	$14.1B
Incyte (INCY)	$13.3B
Moderna (MRNA)	$12.5B
Exelixis (EXEL)	$12.2B
BioMarin Pharmaceutical (BMRN)	$11.2B
Ascendis Pharma (ASND)	$10.8B
QIAGEN (QGEN)	$10.7B
Swedish Orphan Biovitrum (BIOVF)	$10.6B
Exact Sciences (EXAS)	$9.8B
Verona Pharma American Depositary Share (VRNA)	$8.9B
Bio-Techne Corp (TECH)	$8.4B
Blueprint Medicines (BPMC)	$8.3B
Roivant Sciences (ROIV)	$7.9B
Legend Biotech (LEGN)	$7.7B